Central Square Medical Center Inc is categorized under in Philadelphia, PA and active since 1979.
Central Square Medical Center Inc was established in 1979, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a business, which does work in the B2B market, and is classified as a , under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Evelyn Palat, Office Manager at the company’s single location by writing to 2451 Grant Avenue # 1b, Philadelphia, Pennsylvania PA 19114 or by phoning (215) 671-8900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central Square Medical Center Inc |
| Contact Person: | Evelyn Palat, Office Manager |
| Address: | 2451 Grant Avenue # 1b, Philadelphia, Pennsylvania 19114 |
| Phone Number: | (215) 671-8900 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1979 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | |
| SIC Code: | 8031 |
| NAICS Code: | 6211110 |
| Share This Business: |
Central Square Medical Center Inc was started in 1979 to provide professional under the SIC code 8031 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Evelyn Palat, Office Manager for inquiries that concern Central Square Medical Center Inc by calling the company number (215) 671-8900, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Square Medical Center Inc can be found at the coordinates 40.07959,-75.02621 as well as the street address 2451 Grant Avenue # 1b in Philadelphia, Pennsylvania 19114.
For its online presence, you may visit Central Square Medical Center Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.